放化疗与单纯放疗对乳腺癌保乳术后患者免疫功能的影响分析

目的分析放化疗与单纯放疗对乳腺癌保乳术后患者免疫功能的影响。方法研究选择在我院接受保乳手术的110例乳腺癌患者,在我院治疗时间为2016年1月-2018年1月。根据接受的治疗方案不同,分为对照组和研究组。对照组术后予以放疗,研究组术后开展放化疗,对比两组免疫功能指标和预后情况。结果对比接受治疗后CD4+、CD8+、CD3+等指标水平两组无明显差异,P>0.05;对比两组复发率研究组低于对照组P<0.05。结论乳腺癌保乳手术后接受放化疗与单纯放疗相比对患者免疫功能影响并不明显,但降低了复发率,对预后及生存率提高具有积极的意义。

To analyze the effect of radiotherapy and chemotherapy alone on the immune function of breast cancer patients after breast-conserving surgery.Methods:A total of 110 breast cancer patients who underwent breast-conserving surgery in our hospital were enrolled.The treatment time in our hospital was from January 2016 to January 2018.According to the different treatment options,they were divided into control group and study group.Radiotherapy was given to the control group.Radiotherapy and chemotherapy were performed in the study group.The immune function indexes and prognosis of the two groups were compared.Results:There was no significant difference in the levels of CD4+,CD8+,CD3+and other indicators after treatment,P>0.05.The recurrence rate of the two groups was lower than that of the control group(P<0.05).Conclusion:The effect of chemoradiotherapy on breast cancer after breast-conserving surgery is not obvious,but it reduces the recurrence rate and has positive significance for prognosis and survival.